Test Price
2,800 AED✅ Home Collection Available
AR Gene (Androgen Receptor) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين مستقبلات الأندروجين (AR) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
✅ Diagnostic Accuracy 99.9% – ISO 9001:2015 Certified Processing
✅ VIP Mobile Phlebotomy & Cold-Chain Home Collection (8 AM – 11 PM)
✅ Telephonic Post-Test Clinical Guidance with DHA-Licensed Specialists
✅ Direct Billing Verification via WhatsApp: +971 54 548 8731
Facility License: 9834453 | Full compliance with Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 & UAE PDPL
ملخص تنفيذي
دقة تشخيصية 99.9% مع معالجة معتمدة من ISO 9001:2015 لتحليل جين AR المرتبط بمتلازمة عدم الحساسية الجزئي للأندروجين وقابلية سرطان الثدي.
سحب منزلي فاخر وسلسلة تبريد معتمدة (8 صباحاً – 11 مساءً)، استشارة وراثية بعد الفحص، والتحقق من التغطية التأمينية عبر واتساب.
Test Overview
This AR gene test uses Next Generation Sequencing (NGS) to comprehensively analyse the entire androgen receptor coding region, identifying pathogenic variants linked to partial androgen insensitivity syndrome (PAIS) and hereditary breast cancer susceptibility. It is designed for UAE patients requiring a definitive molecular diagnosis under DHA 2026 guidelines.
يُحلل الاختبار تسلسل جين مستقبلات الأندروجين بالكامل باستخدام تقنية NGS لتشخيص متلازمة عدم الحساسية الجزئي للأندروجين وتقييم المخاطر الوراثية لسرطان الثدي، وفقاً لإرشادات هيئة الصحة بدبي لعام 2026.
| Feature | Our AR Gene NGS Test | Conventional Single‑Gene Sequencing |
|---|---|---|
| Methodology | High-coverage NGS (Illumina platform) – full gene analysis | Sanger sequencing of selected hotspots only |
| Sensitivity | 99.9% diagnostic sensitivity for all coding variants | May miss deep intronic or novel mutations |
| Turnaround Time | 3–4 weeks in an ISO 9001 lab | Often 5–7 weeks, no ISO guarantee |
| Home Collection | Paid hospital-grade cold-chain collection | Not typically included |
| Cost | 2800 AED | Varies, often higher when factoring genetic counselling |
Pre‑Test Requirements
- Detailed clinical history, including any signs of androgen insensitivity or breast cancer in the family.
- Mandatory genetic counselling session to draw a pedigree chart of affected family members (in person or tele‑consult).
- Signed informed consent (for minors, parental consent as per UAE CDS Law 2026).
- Specimen: 3–5 ml venous blood (EDTA tube), extracted DNA, or a dried blood spot on an FTA card.
مطلوب تاريخ سريري مفصل واستشارة وراثية لتخطيط الشجرة العائلية، مع الموافقة المستنيرة.
Physician Insight & Safety Protocol
“As a clinical geneticist, I strongly underscore that a pathogenic AR variant does not guarantee clinical expression; its interpretation must be correlated with detailed phenotypic findings and a complete family history. Please consult a specialist before acting on any genetic result.” – Dr. Prabhakar Reddy, DHA 61713011.
⚠️ Medication Warning
Do not discontinue any prescribed medication or hormone therapy without consulting your treating physician. Genetic findings do not replace medical management.
Exclusion Criteria & Emergency Red Flags
- Inability to provide a venous blood sample or sign informed consent (legal guardians may sign for minors per CDS Law 2026).
- Acute medical emergency – if you experience severe abdominal pain, breathing difficulty, or collapse, call 998 immediately.
- This test does not replace urgent clinical care; it is intended for stable patients only.
الحالات الطارئة الحادة تمنع إجراء هذا الفحص المنزلي؛ الاتصال بالطوارئ على 998 فوراً.
Patient FAQ & Clinical Guidance
1. What does the AR gene test detect and how is it performed?
Snippet: The AR gene test detects pathogenic mutations in the androgen receptor gene linked to partial androgen insensitivity syndrome and breast cancer risk using Next Generation Sequencing of DNA.
Our laboratory analyses the entire AR gene from a blood sample (or dried blood spot) with high-coverage NGS, ensuring even rare variants are identified. The process includes bioinformatic filtering and interpretation by clinical geneticists.
يكشف تحليل جين AR عن الطفرات المرتبطة بمتلازمة عدم الحساسية الجزئي للأندروجين وخطر سرطان الثدي عبر تقنية التسلسل الجيني (NGS) لعينة الدم.
2. How long until results are available and what is the cost?
Snippet: Results are delivered within 3 to 4 weeks, and the test is priced at 2800 AED including a post‑test clinical guidance session.
The TAT allows for rigorous sequencing, data analysis, and multi‑stage review. Insurance reimbursement can be pre‑verified via WhatsApp; contact +971 54 548 8731.
النتائج خلال 3 إلى 4 أسابيع، بسعر 2800 درهم إماراتي شامل استشارة ما بعد الفحص. التحقق من التأمين عبر واتساب.
3. Is a doctor’s referral required for this in the UAE?
Snippet: A referral from an endocrinologist, oncologist, or clinical geneticist is recommended but self‑request with informed consent is permitted under DHA guidelines.
Mandatory genetic counselling is included to interpret the results responsibly. Minors require parental consent in compliance with the UAE CDS Law 2026.
يُوصى بإحالة من طبيب غدد صماء أو أورام أو استشاري وراثة، مع إمكانية الطلب الذاتي بموافقة مستنيرة وفق أنظمة هيئة الصحة بدبي.
All testing adheres to UAE PDPL, DHA standards, and ISO 9001:2015. Cert: INT/EGQ/2509DA/3139. © 2026 AR Gene UAE Service.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians